CXADRP2

Across TCGA pan-cancer cohorts, CXADRP2 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of CXADRP2’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where CXADRP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CXADRP2 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

UCEC, BRCA, and PRAD are the cancer types where CXADRP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CXADRP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	+0.034	.023	4	view →
BRCA	All	All	+0.014	.003	4	view →
PRAD	All	All	+0.316	.008	2	view →
LUAD	Male	All	+0.020	.041	1	view →
STAD	All	All	−0.019	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

CXADRP2–UCEC

Open the UCEC breakdown →